Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
Aslan Pharmaceuticals Ltd
Operating Income
Aslan Pharmaceuticals Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Aslan Pharmaceuticals Ltd
NASDAQ:ASLN
|
Operating Income
-$12.8m
|
CAGR 3-Years
23%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
See Also
What is Aslan Pharmaceuticals Ltd's Operating Income?
Operating Income
-12.8m
USD
Based on the financial report for Sep 30, 2023, Aslan Pharmaceuticals Ltd's Operating Income amounts to -12.8m USD.
What is Aslan Pharmaceuticals Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
12%
Over the last year, the Operating Income growth was 55%. The average annual Operating Income growth rates for Aslan Pharmaceuticals Ltd have been 23% over the past three years , 12% over the past five years .